Democratic drug reform bill could sacrifice future savings to keep costs down

Published



Democratic legislation aimed at prescription drugs could sacrifice future savings in healthcare to reduce costs in the short term.

House Democrats have proposed HR 3, a bill that would require the federal government to negotiate prices with drug manufacturers. The negotiated price of a drug could not exceed 120% of the average price of that drug in countries where costs are lower, including Australia, Canada, France, Germany, Japan, and the United Kingdom.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.